25 LLC’s CVS Health CVS Stock Holding History

25 LLC’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-550	Closed	-$39.2K	–	156
2023 Q2	$39.2K	Sell	550 -6	-1%	-$427	0.02%	92
2023 Q1	$38.7K	Buy	+556	New	+$46.6K	0.02%	93

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

25 LLC's CVS Position: Q3 2023 in Review

25 LLC sold out of CVS Health (CVS) in Q3 2023, closing a stake of 550 shares — an estimated $39.2K sold.

25 LLC first reported a position in CVS in Q1 2023 and held it in 2 quarters. The position peaked at $39.2K in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

25 LLC reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
25 LLC sold 550 CVS Health shares in Q3 2023, an estimated $39.2K.
25 LLC first reported a position in CVS Health in Q1 2023 and held it in 2 quarters.
25 LLC's CVS Health position peaked at $39.2K in Q2 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.